You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Daklinza

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCV Trial in Cairo (Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets)

Recruiting
  • HCV
  • Sofosbuvir 200 MG Oral Tablet plus Daclatasvir 30 mg Oral tablets
  • Cairo, Egypt
    Faculty of Medicine, Ain-Shams University Research Institute-Cli
May 2, 2023

HIV-1-infection, Hepatic Impairment Trial in Smolensk (Elpida®, Dolutegravir, Sofosbuvir)

Completed
  • HIV-1-infection
  • Hepatic Impairment
  • Smolensk, Russian Federation
    Regional State Budgetary Healthcare Institution "Smolensk Region
Jan 10, 2022

Chronic Hepatitis C Infection, HBV Coinfection, Hepatitis B Reactivation Trial in Hong Kong (Ledipasvir/Sofosbuvir, Sofosbuvir

Completed
  • Chronic Hepatitis C Infection
  • +2 more
  • Hong Kong, Hong Kong, China
    Humanity and Health GI and Liver Centre
Aug 27, 2021

COVID Trial in Tanta (sofosbuvir, Sofosbuvir ledipsavir, Daclatasvir)

Recruiting
  • COVID
  • Tanta, Egypt
    Sherief Abd-Elsalam
Dec 3, 2020

Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)

Completed
Has Results
  • Chronic Hepatitis C
  • +2 more
  • (no location specified)
Jul 9, 2021

Covid19 Trial in Tanta (Sofosbuvir, Daclatasvir)

Unknown status
  • Covid19
  • Tanta, Egypt
    Cairo and Tanta Universitities
Dec 2, 2020

Hepatitis C, Diabetes, Insulin Resistance Trial in Nijmegen (Daclatasvir, Metformin)

Completed
  • Hepatitis C
  • +2 more
  • Nijmegen, Netherlands
    CRCN, Radboud University Medical Center
Dec 4, 2020

Hepatitis C, HIV Trial in Nijmegen (Daclatasvir, Atazanavir, Ritonavir)

Completed
  • Hepatitis C
  • HIV
  • Nijmegen, Netherlands
    CRCN, Radboud University Medical Center
Dec 4, 2020

Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)

Completed
Has Results
  • Hepatitis C, Chronic
  • Bilaspur, Chhattisgarh, India
    YR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
Apr 26, 2021

Daclatasvir in Treatment of Chronic Hepatitis C in Adults

Completed
  • Hepatitis C
  • Non-Interventional
  • Benito Juarez, Distrito Federal, Mexico
  • +1 more
Mar 17, 2020

Chronic Hepatitis C Virus Infection Trial ((SOF and DCV), (SOF, DCV, and RBV))

Completed
  • Chronic Hepatitis C Virus Infection
  • (SOF and DCV)
  • (SOF, DCV, and RBV)
  • (no location specified)
May 13, 2020

the Pulmonary Safety of Antihepatitis C Treatment

Not yet recruiting
  • Hepatitis C
  • sofosbuvir \daclatsvir
  • (no location specified)
Mar 26, 2020

Hepatitis C Trial in Seoul

Completed
  • Hepatitis C
    • Seoul, Korea, Republic of
      Local Institution
    Jan 6, 2022

    Chronic Hepatitis C Virus Infection Trial in Bani Sweif (SOF/SMV/DCV/RBV)

    Completed
    • Chronic Hepatitis C Virus Infection
    • Bani Sweif, Egypt
      Health Administration at Beni-Seuf
    May 10, 2020

    Chronic Hepatitis C Trial in Cairo (sofosbuvir plus daclatasvir, Sofosbuvir plus Ledipasvir)

    Unknown status
    • Chronic Hepatitis C
    • sofosbuvir plus daclatasvir
    • Sofosbuvir plus Ledipasvir
    • Cairo, Abbasseya, Egypt
      El Demerdash Hospital
    Dec 28, 2019

    Hepatitis C, Chronic Trial in Jilin (SH229 tablets, Daclatasvir diHCl)

    Unknown status
    • Hepatitis C, Chronic
    • SH229 tablets
    • Daclatasvir dihydrochloride
    • Jilin, Jiangsu, China
      The First Hospital of Jilin University
    Aug 25, 2019

    Hepatitis C, Cirrhosis Trial in Coronado (daclatasvir, Sofosbuvir, Sovaldi, Ribavirin)

    Completed
    Has Results
    • Hepatitis C
    • Cirrhosis
    • Coronado, California
      Southern California Research Center
    Apr 23, 2019

    Hepatitis C Trial in Kaohsiung (daclatasvir, asunaprevir, Ribavirin)

    Completed
    • Hepatitis C
    • Kaohsiung, Taiwan
      Kaohsiung Medical Universsity
    Jan 7, 2019

    Decompensated Cirrhosis Trial (Sofosbuvir 400mg (Sovaldi) + Daclatasvir 60 mg (Daklinza) + Ribavirin 200 mg (Rebetol), vitamin K

    Completed
    • Decompensated Cirrhosis
    • Sofosbuvir 400mg (Sovaldi) + Daclatasvir 60 mg (Daklinza) + Ribavirin 200 mg (Rebetol)
    • vitamin K (Phytomenadione) 10 mg+ furosemide and spironolactone (Lasilactone) 50 mg + milk thistle (Silymarin) 140 mg + Albumin infusion
    • (no location specified)
    Dec 3, 2018

    Chronic Hepatitis C Genotype 1b Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Daclatasvir)

    Completed
    • Chronic Hepatitis C Genotype 1b
    • Moscow, Russian Federation
    • +3 more
    Dec 18, 2018

    Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (sofosbuvir and daclatasvir, ledipasvir/sofosbuvir)

    Completed
    • Chronic Hepatitis C Infection
    • Beijing, Beijing, China
    • +1 more
    Mar 16, 2018

    Chronic Hepatitis C Infection Trial in Beijing, Hong Kong (SOF+RBV, SOF+DCV, LDV/SOF)

    Completed
    • Chronic Hepatitis C Infection
    • Beijing, Beijing, China
    • +1 more
    Mar 16, 2018

    Declatasvir in Egyptian Hepatitis C Virus Genotype 4

    Unknown status
    • Hepatitis C
    • Daclatasvir 60 MG Oral Tablet [Daklinza]
    • +2 more
    • (no location specified)
    Oct 8, 2017

    Hepatitis c and Vitamin D and Iron Status

    Unknown status
    • Hepatitis C
    • Sofosbuvir 400 mg
    • Daclatasvir 60 mg/day
    • (no location specified)
    May 23, 2017

    Chronic Hepatitis C Trial (Ledipasvir-Sofosbuvir, Daclatasvir-Sofosbuvir)

    Completed
    • Chronic Hepatitis C
    • (no location specified)
    Jun 14, 2017